Revvity ROE 2010-2024 | RVTY
Revvity ROE - Return on Equity Historical Data | |||
---|---|---|---|
Date | TTM Net Income | Shareholder's Equity | Return on Equity |
2024-12-31 | $0.27B | $7.67B | 3.45% |
2024-09-30 | $0.25B | $7.92B | 3.22% |
2024-06-30 | $0.17B | $7.87B | 2.16% |
2024-03-31 | $0.15B | $7.85B | 1.92% |
2023-12-31 | $0.69B | $7.87B | 8.81% |
2023-09-30 | $0.74B | $7.69B | 9.58% |
2023-06-30 | $0.82B | $7.87B | 10.78% |
2023-03-31 | $0.96B | $8.03B | 12.97% |
2022-12-31 | $0.57B | $7.38B | 7.90% |
2022-09-30 | $0.63B | $7.07B | 8.84% |
2022-06-30 | $0.67B | $7.17B | 9.48% |
2022-03-31 | $0.74B | $7.19B | 11.61% |
2021-12-31 | $0.94B | $7.14B | 16.88% |
2021-09-30 | $1.13B | $6.96B | 23.93% |
2021-06-30 | $1.18B | $4.24B | 31.09% |
2021-03-31 | $1.07B | $4.00B | 30.80% |
2020-12-31 | $0.73B | $3.74B | 22.94% |
2020-09-30 | $0.41B | $3.23B | 14.03% |
2020-06-30 | $0.30B | $2.97B | 10.49% |
2020-03-31 | $0.23B | $2.76B | 8.26% |
2019-12-31 | $0.23B | $2.81B | 8.39% |
2019-09-30 | $0.23B | $2.71B | 8.80% |
2019-06-30 | $0.25B | $2.71B | 9.60% |
2019-03-31 | $0.25B | $2.64B | 9.58% |
2018-12-31 | $0.24B | $2.59B | 9.31% |
2018-09-30 | $0.13B | $2.57B | 4.97% |
2018-06-30 | $0.14B | $2.52B | 5.54% |
2018-03-31 | $0.28B | $2.56B | 11.16% |
2017-12-31 | $0.29B | $2.50B | 12.10% |
2017-09-30 | $0.40B | $2.54B | 17.09% |
2017-06-30 | $0.37B | $2.44B | 16.38% |
2017-03-31 | $0.23B | $2.21B | 10.53% |
2016-12-31 | $0.23B | $2.15B | 11.11% |
2016-09-30 | $0.24B | $2.14B | 11.31% |
2016-06-30 | $0.23B | $2.09B | 11.28% |
2016-03-31 | $0.22B | $2.05B | 10.51% |
2015-12-31 | $0.21B | $2.11B | 10.16% |
2015-09-30 | $0.18B | $2.05B | 8.46% |
2015-06-30 | $0.16B | $2.12B | 7.82% |
2015-03-31 | $0.16B | $2.06B | 7.93% |
2014-12-31 | $0.16B | $2.04B | 7.67% |
2014-09-30 | $0.19B | $2.06B | 9.48% |
2014-06-30 | $0.19B | $2.06B | 9.55% |
2014-03-31 | $0.17B | $2.03B | 8.66% |
2013-12-31 | $0.17B | $1.99B | 8.78% |
2013-09-30 | $0.08B | $1.92B | 4.45% |
2013-06-30 | $0.07B | $1.86B | 3.91% |
2013-03-31 | $0.08B | $1.83B | 4.21% |
2012-12-31 | $0.07B | $1.94B | 3.71% |
2012-09-30 | $0.00B | $1.94B | 0.16% |
2012-06-30 | $0.01B | $1.89B | 0.53% |
2012-03-31 | $0.01B | $1.88B | 0.31% |
2011-12-31 | $0.01B | $1.84B | 0.42% |
2011-09-30 | $0.39B | $1.95B | 20.07% |
2011-06-30 | $0.36B | $1.96B | 19.42% |
2011-03-31 | $0.39B | $1.91B | 21.83% |
2010-12-31 | $0.39B | $1.93B | 22.64% |
2010-09-30 | $0.13B | $1.71B | 7.93% |
2010-06-30 | $0.13B | $1.64B | 8.12% |
2010-03-31 | $0.10B | $1.63B | 5.97% |
2009-12-31 | $0.08B | $1.63B | 5.26% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $12.712B | $2.755B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $146.516B | 27.37 |
Elevance Health (ELV) | United States | $98.469B | 13.19 |
CVS Health (CVS) | United States | $85.419B | 12.50 |
Cencora (COR) | United States | $53.926B | 19.57 |
DiDi Global (DIDIY) | China | $23.525B | 0.00 |
Natera (NTRA) | United States | $19.117B | 0.00 |
BioMerieux (BMXMF) | France | $14.914B | 0.00 |
ICON (ICLR) | Ireland | $14.132B | 12.84 |
Solventum (SOLV) | United States | $13.154B | 12.27 |
Avantor (AVTR) | United States | $11.045B | 16.21 |
CochLear (CHEOY) | Australia | $10.877B | 0.00 |
Doximity (DOCS) | United States | $10.834B | 56.34 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
Viatris (VTRS) | United States | $10.397B | 3.29 |
Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
HealthEquity (HQY) | United States | $7.644B | 37.60 |
Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
Organon (OGN) | United States | $3.841B | 3.91 |
Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
Sotera Health (SHC) | United States | $3.305B | 19.11 |
BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
Concentras Parent (CON) | United States | $2.781B | 14.47 |
GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
Progyny (PGNY) | United States | $1.908B | 42.15 |
Agilon Health (AGL) | United States | $1.785B | 0.00 |
Premier (PINC) | United States | $1.760B | 11.27 |
PACS (PACS) | United States | $1.713B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
CareDx (CDNA) | United States | $0.984B | 16.75 |
AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
Embecta (EMBC) | United States | $0.741B | 5.08 |
QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
Enhabit (EHAB) | United States | $0.444B | 41.86 |
Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
SBC Medicals (SBC) | United States | $0.329B | 0.00 |
DocGo (DCGO) | United States | $0.269B | 11.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
Nutex Health (NUTX) | United States | $0.256B | 5.10 |
LifeMD (LFMD) | United States | $0.243B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
Beauty Health (SKIN) | United States | $0.168B | 0.00 |
Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
So-Young (SY) | China | $0.098B | 0.00 |
Biodesix (BDSX) | United States | $0.091B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
OncoCyte (OCX) | United States | $0.088B | 0.00 |
Oncology Institute (TOI) | United States | $0.086B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
NeueHealth (NEUE) | United States | $0.056B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
ModivCare (MODV) | United States | $0.019B | 6.57 |
SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
KindlyMD (KDLY) | United States | $0.010B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.001B | 0.00 |
Aclarion (ACON) | United States | $0.000B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |